Trivalent arsenic species. Analysis, stability, and interaction with a protein.

Arsenic Exposure and Health Effects V

Volumn , Issue , 2003, Pages 51-68

  Jiang, Guifeng ^d   Lu, Xiufen ^a   Gong, Zhilong ^d   Cullen, William R ^b   Chris Le, X ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d NONE

Author keywords

Analytical technique; Arsenic speciation; Metabolism; Metallothionein; Methylation; Protein interaction; Stability

Indexed keywords

ABSORPTION SPECTROSCOPY; ALKYLATION; BINS; CHROMATOGRAPHY; CONVERGENCE OF NUMERICAL METHODS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRIDES; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; MASS SPECTROMETRY; METABOLISM; METALS; METHYLATION; ORGANIC POLYMERS; PROTEINS; SIZE EXCLUSION CHROMATOGRAPHY; SIZE SEPARATION; SOLVENT EXTRACTION; SPECTROMETRY;

ANALYTICAL TECHNIQUE; ARSENIC SPECIATION; DIETHYLAMMONIUM DIETHYLDITHIOCARBAMATE; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRIES (ICPMS); METALLOTHIONEINS; MONOMETHYLARSONOUS ACIDS; PROTEIN INTERACTION; QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY;

ARSENIC;

EID: 8644276576     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451441-7/50005-1     Document Type: Chapter

References (54)

1. Adams S.R., Campbell R.E., Gross L.A., Martin B.R., Walkup G.K., Yao Y., Llopis J., Tsien R.Y. New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications. J. Am. Chem. Soc. 2002, 124:6063-6076.
2. Aposhian H.V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 1997, 37:397-419.
3. Aposhian H.V., Zakharyan R.A., Wildfang E.K., Healy S.M., Gailer J., Radabaugh T.R., Bogdan G.M., Powell L.A., Aposhian M.M. How is inorganic arsenic detoxified?. Arsenic Exposure and Health Effects 1999, 289-297. Elsevier, Amsterdam. W.R. Chappell, C.O. Abernathy, R.L. Calderon (Eds.).
4. III) in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 2000, 13:693-697.
5. Aposhian H.V., Zheng B., Aposhian M.M., Le X.C., Cebrian M.E., Cullen W.R., Zakharyan R.A., Ma M., Dart R.C., Cheng Z., Andrews P., Yip L., O'Malley G.F., Maiorino R.M., Van Voorhies W., Healy S.M., Titcomb A. DMPS-arsenic challenge test: modulation of arsenic species, including monomethy-larsonous acid, excreted in human urine. Toxicol. Appl. Pharmacol. 2000, 165:74-83.
6. Burrows G.J., Turner E.E. A new type of compound containg arsenic. J. Chem. Soc. Transact. 1920, 117:1373-1383.
7. Chen C.M., Mobley H.L., Rosen B.P. Separate resistances to arsenate and arsenite (antimonate) encoded by the arsenical resistance operon of R factor R773. J. Bacteriol. 1985, 161:758-763.
8. Cline D.J., Thorpe C., Schneider J.P. Effects of As(III) binding on alpha-helical structure. J. Am. Chem. Soc. 2003, 125:2923-2929.
9. Cohen S.M., Arnold L.L., Uzvolgyi E., Cano M., St.John M., Yamamoto S., Lu X., Le X.C. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 2002, 15:1150-1157.
10. Cullen W.R., Reimer K.J. Arsenic speciation in the environment. Chem. Rev. 1989, 89:713-764.
11. Cullen W.R., McBride B.C., Reglinski J. The reduction of trimethylarsine oxide to trimethylarsine by thiols: a mechanistic model for the biological reduction of arsenicals. J. Inorg. Biochem. 1984, 21:179-194. see also.
12. Cullen W.R., McBride B.C., Manji H., Pickett A.W., Reglinski J. The metabolism of methylarsine oxide and sulfide. Appl. Organomet. Chem. 1989, 3:71-78.
13. Del Razo L.M., Styblo M., Cullen W.R., Thomas D.J. Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol. 2001, 174:282-293.
14. Farrer B.T., McClure C.P., Penner-Hahn J.E., Pecoraro V.L. Arsenic(III)-cysteine interactions stabilize three-helix bundles in aqueous solution. Inorg. Chem. 2000, 39:5422-5423.
15. Feldmann J., Lai V.W.M., Cullen W.R., Ma M., Lu X., Le X.C. Sample preparation and storage can change arsenic speciation in human urine. Clin. Chem. 1999, 45:1988-1997.
16. Gong Z., Lu X., Cullen W.R., Le X.C. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J. Anal. At. Spectrom. 2001, 16:1409-1413.
17. Gong Z., Jiang G., Cullen W.R., Aposhian H.V., Le X.C. Determination of arsenic metabolic complex excreted in human urine after administration of sodium 2,3-dimercapto-1-propane sulfonate. Chem. Res. Toxicol. 2002, 15:1318-1323.
18. Gong Z., Lu X., Wang Z., Cullen W.R., Le X.C. Preservation of monomethylarsonous acid and dimethylarsinic acid using diethyldithiocarbamate for arsenic speciation analysis 2003, submitted for publication.
19. Goyer R.A. Toxic effects of metals. Casarett and Doull's Toxicology: The Basic Science of Poisons 1996, 696-698. McGraw-Hill, New York. C.D. Klaassen (Ed.).
20. Griffin B.A., Adams S.R., Tsien R.Y. Specific covalent labeling of recombinant protein molecules inside live cells. Science 1998, 281:269-272.
21. Hasegawa H., Sohrin Y., Matsui M., Hojo M., Kawashima M. Speciation of arsenic in natural waters by solvent extraction and hydride generation atomic absorption spectrometry. Anal. Chem. 1994, 66:3247-3252.
22. Ji G., Silver S. Reduction of arsenate to arsenite by the ArsC protein of the arsenic resistance operon of Staphylococcus aureus plasmid pI258. Proc. Natl Acad. Sci. USA 1992, 89:9474-9478.
23. Jiang G., Gong Z., Li X-F., Cullen W.R., Le X.C. Interaction of trivalent arsenicals with metallothionein. Chem. Res. Toxicol. 2003, 16:873-880.
24. Johnson J.M., Voegtlin C. Arsenic derivatives of cysteine. J. Biol. Chem. 1930, 89:27-31.
25. Le X.C., Ma M. Short-column liquid chromatography with hydride generation atomic fluorescence detection for the speciation of arsenic. Anal. Chem. 1998, 70:1926-1933.
26. Le X.C., Ma M., Wong N.A. Speciation of arsenic compounds using high performance liquid chromatography at elevated temperature and selective hybride generation atomic fluorescence detection. Anal. Chem. 1996, 68:4501-4506.
27. Le X.C., Lu X., Ma M., Cullen W.R., Aposhian H.V., Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 2000, 72:5172-5177.
28. Le X.C., Ma M., Lu X., Cullen W.R., Aposhian H.V., Zheng B. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect. 2000, 108:1015-1018.
29. Lin S., Cullen W.R., Thomas D.J. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 1999, 12:924-930.
30. Lin S., Shi Q., Nix F.B., Styblo M., Beck M.A., Herbin-Davis K.M., Hall L.L., Simeonsson J.B., Thomas D.J. A novel S-adenosyl-l-methionine:arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem. 2002, 277:10795-10803.
31. Lu X., Gong Z., Ma M., Cullen W.R., Aposhian H.V., Zheng B., Gurzau E.S., Le X.C. Speciation of human urinary arsenic including the trivalent methylation metabolites. Arsenic Exposure and Health Effects 2001, 339-352. Elsevier, Oxford. W.R. Chappell, C.O. Abernathy, R.L. Calderon (Eds.).
32. Ma M., Le X.C. Effect of arsenosugar ingestion on urinary arsenic speciation. Clin. Chem. 1998, 44:539-550.
33. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 2001, 14:371-378.
34. Mass M.J., Tennant A., Roop R.C., Cullen W.R., Styblo M., Thomas D.J., Kligerman A.D. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 2001, 14:355-361.
35. Merijanian A., Zingaro R. Arsine Oxides. Inorg. Chem. 1966, 5:187-191.
36. Nesnow S., Roop B.C., Lambert G., Kadiiska M., Mason R.P., Cullen W.R., Mass M.J. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 2002, 15:1627-1634.
37. NRC Arsenic in Drinking Water 1999, National Research Council, Washington, DC.
38. III) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 2000, 163:203-207.
39. 50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 2001, 14:651-656.
40. Sampayo-Reyes A., Zakharyan R.A., Healy S.M., Aposhian H.V. Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem. Res. Toxicol. 2000, 13:1181-1186.
41. Serves S.V., Charalambidis Y.C., Sotiropoulos D.N., Ioannou P.V. Reaction of arsenic(III) oxide, arsenous and arsenic acids with thiols. Phosphorus, Sulfur, and Silicon and the Related Elements 1995, 105:109-116.
42. III) by red blood cells. Chem. Res. Toxicol. 2001, 14:1446-1452.
43. Sohrin Y., Matsui M., Kawashima M., Hojo M., Hasegawa H. Arsenic biogeochemistry affected by eutrophication in Lake Biwa, Japan. Environ. Sci. Technol. 1997, 31:2712-2720.
44. Stevens S.Y., Hu W., Gladysheva T., Rosen B.P., Zuiderweg E.R.P., Lee L. Secondary structure and fold homology of the ArsC protein from the Escherichia coli arsenic resistance plasmid R773. Biochemistry 1999, 38:10178-10186.
45. Styblo M., Thomas D.J. In vitro inhibition of glutathione reductase by arsenotriglutathione. Biochem. Pharmacol. 1995, 49:971-974.
46. Styblo M., Delnomdedieu M., Thomas D.J. Biological mechanisms and toxicological consequences of the methylation of arsenic. Toxicology of Metals-Biochemical Aspects, Handbook of Experimental Pharmacology 1995, 407-433. Springer, Berlin. R.A. Goyer, G. Cherian (Eds.).
47. Styblo M., Serves S.V., Cullen W.R., Thomas D.J. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 1997, 10:27-33.
48. Styblo M., Serves S.V., Cullen W.R., Thomas D.J. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 1997, 10:27-33.
49. Styblo M., Vega L., Germolec D.R., Luster M.I., Del Razo L.M., Wang C., Cullen W.R., Thomas D.J. Metabolism and toxicity of arsenicals in cultured cells. Arsenic Exposure and Health Effects 1999, 311-323. Elsevier, Amsterdam. W.R. Chappell, C.O. Abernathy, R.L. Calderon (Eds.).
50. Vahter M. Variation in human metabolism of arsenic. Arsenic Exposure and Health Effects 1999, 267-279. Elsevier, Amsterdam. W.R. Chappell, C.O. Abernathy, R.L. Calderon (Eds.).
51. Yamauchi H., Fowler B.A. Toxicity and metabolism of inorganic and methylated arsenicals. Arsenic in the Environment, Part II: Human Health and Ecosystem Effects 1994, 35-43. Wiley, New York. J.O. Nriagu (Ed.).
52. Zakharyan R.A., Wu Y., Bogdan G.M., Aposhian H.V. Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem. Res. Toxicol. 1995, 8:1029-1038.
53. III) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 1999, 158:9-15.
54. V) reductase is a member of the glutathione-S-transferase superfamily. Chem. Res. Toxicol. 2001, 14:1051-1057.